Novo Integrated Sciences Inc (NVOS)
0.1499
-0.02
(-13.35%)
USD |
NASDAQ |
Nov 05, 16:00
0.1177
-0.03
(-21.48%)
After-Hours: 18:55
Novo Integrated Sciences Enterprise Value: 4.018M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.018M |
| November 01, 2024 | 4.092M |
| October 31, 2024 | 4.233M |
| October 30, 2024 | 4.341M |
| October 29, 2024 | 4.376M |
| October 28, 2024 | 4.574M |
| October 25, 2024 | 4.862M |
| October 24, 2024 | 4.951M |
| October 23, 2024 | 4.904M |
| October 22, 2024 | 5.102M |
| October 21, 2024 | 4.923M |
| October 18, 2024 | 5.048M |
| October 17, 2024 | 5.908M |
| October 16, 2024 | 6.075M |
| October 15, 2024 | 6.058M |
| October 14, 2024 | 6.308M |
| October 11, 2024 | 5.727M |
| October 10, 2024 | 5.448M |
| October 09, 2024 | 5.654M |
| October 08, 2024 | 5.428M |
| October 07, 2024 | 5.856M |
| October 04, 2024 | 5.477M |
| October 03, 2024 | 5.308M |
| October 02, 2024 | 5.445M |
| October 01, 2024 | 5.441M |
| Date | Value |
|---|---|
| September 30, 2024 | 6.075M |
| September 27, 2024 | 6.323M |
| September 26, 2024 | 6.171M |
| September 25, 2024 | 6.344M |
| September 24, 2024 | 6.525M |
| September 23, 2024 | 6.382M |
| September 20, 2024 | 6.609M |
| September 19, 2024 | 6.971M |
| September 18, 2024 | 6.794M |
| September 17, 2024 | 6.117M |
| September 16, 2024 | 6.399M |
| September 13, 2024 | 6.510M |
| September 12, 2024 | 6.514M |
| September 11, 2024 | 5.512M |
| September 10, 2024 | 5.370M |
| September 09, 2024 | 6.056M |
| September 06, 2024 | 6.148M |
| September 05, 2024 | 6.251M |
| September 04, 2024 | 6.456M |
| September 03, 2024 | 6.314M |
| August 30, 2024 | 6.718M |
| August 29, 2024 | 6.807M |
| August 28, 2024 | 6.628M |
| August 27, 2024 | 6.980M |
| August 26, 2024 | 7.613M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.018M
Minimum
Nov 04 2024
207.21M
Maximum
Feb 01 2021
50.09M
Average
45.53M
Median
Mar 01 2022
Enterprise Value Benchmarks
| American Shared Hospital Services | 31.12M |
| Astrana Health Inc | 2.392B |
| Cryo-Cell International Inc | 68.02M |
| P3 Health Partners Inc | 316.56M |
| Biote Corp | 255.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.74M |
| Revenue (Quarterly) | 3.152M |
| Total Expenses (Quarterly) | 5.672M |
| EPS Diluted (Quarterly) | -0.74 |
| Gross Profit Margin (Quarterly) | 28.46% |
| Profit Margin (Quarterly) | -436.0% |
| Earnings Yield | -873.9% |
| Normalized Earnings Yield | -607.78 |